Main Conference Day 3 (30th April 2026)Thursday, 30 April 2026 - CET/CEST (Cent Europe Summer, GMT+2)

• Transitioning from non-scalable adherent systems to robust high-density suspension processes for commercial AAV manufacturing

• Maximizing viral particle yield with systematic triple-transfection process optimisation

• Utilising perfusion strategies to improve full-to-empty capsid ratio

• Overcoming the inherent variability of viral vector production by mastering process robustness & consistency

• When is it beneficial to use continuous processing vs. traditional batch approach?

• Factors to consider:

  • Scalability

  • Product Lifecycle

  • Facility fit

• Cost effective roadmap and strategy

• The Journey of implementing and validating a fully connected, end-to-end continuous purification workflow.

• Overcoming challenges of integration, process control

• Satisfying regulatory requirements

• In-line QC

• Mastering the critical process parameters of LNP manufacturing

• Utilising tools such as microfluidic mixing systems to precisely control particle size and polydispersity.

• Strategies to ensure consistent particle attributes and encapsulation efficiency from lab to GMP scale-up

Have a Solution for This Challenge?

This session is your platform to demonstrate leadership and technical expertise. Present your data, case studies, and innovative solutions to a targeted audience of senior scientists and engineers looking to solve hurdles in their production processes.

To learn more about sponsoring this session, contact us at Partners@informaconnectls.com

• Strategic and technical challenges of pre-competitive data sharing

• How pooling anonymised data can train more robust models

• Governance framework for data sharing

• Enabling truly powerful AI for process optimisation

Have a Solution for This Challenge?

This session is your platform to demonstrate leadership and technical expertise. Present your data, case studies, and innovative solutions to a targeted audience of senior scientists and engineers looking to solve hurdles in their production processes.

To learn more about sponsoring this session, contact us at Partners@informaconnectls.com

• Engineering the upstream process to control CQAs of the antibody backbone: improving conjugation efficiency and stability of subsequent ADCs

• Implementing strategies to minimise aggregation and fragmentation.

• Development of robust upstream processes to enable a more consistent/high-yield downstream conjugation process

Have a Solution for This Challenge?

This session is your platform to demonstrate leadership and technical expertise. Present your data, case studies, and innovative solutions to a targeted audience of senior scientists and engineers looking to solve hurdles in their production processes.

To learn more about sponsoring this session, contact us at Partners@informaconnectls.com

• Approaching automation within buffer preparation: minimising resources needed

• Technologies to automate:

  • In-line dilution and buffer stock management

  • Reducing footprint, minimising labour, ensuring consistency

• Designing and qualifying a robust, end-to-end single-use fluid path for downstream

• Mitigating risks:

  • Extractables and leachables (E&L)

  • Ensuring regulatory compliance

• Unlocking efficiency, footprint reduction, and cost savings

Have a Solution for This Challenge?

This session is your platform to demonstrate leadership and technical expertise. Present your data, case studies, and innovative solutions to a targeted audience of senior scientists and engineers looking to solve hurdles in their production processes.

To learn more about sponsoring this session, contact us at Partners@informaconnectls.com

Have a Solution for This Challenge?

This session is your platform to demonstrate leadership and technical expertise. Present your data, case studies, and innovative solutions to a targeted audience of senior scientists and engineers looking to solve hurdles in their production processes.

To learn more about sponsoring this session, contact us at Partners@informaconnectls.com

• Pinpointing the bottlenecks: do the biggest barriers to productivity come from cell biology, media formulation, bioreactor hardware, or process control?

• Will AI and synthetic biology drive progress to design ‘super-producer’ cell lines in silico?

• Is a diverse range of hosts needed for new modalities, or will a single, universal platform (e.g. advanced CHO cell) dominate?

• Unlocking the next order-of-magnitude increase in productivity: what breakthroughs are needed?

• Approaching change on a large scale

• Planning for phased implementation of sustainability practices

• Seamless integration into existing workflows

• Validation of new processes, technologies, etc.

• Measurable impacts on carbon footprint

• Evaluating performance, purity, and scalability of novel bio-based raw materials for buffer preparation.

• Implementing green chemistry principles to reduce the environmental impact of chromatography.

• Balancing green goals with economic reality and operational efficiency.

• Identifying key cost drivers:

• Raw Materials

• QC

• Labour

• Etc.

• How can targeted automation deliver efficiency?

• Data-driven strategies to deliver significant cost reductions and open accessibility for patients worldwide

• Identifying key cost drivers:

• Raw Materials

• QC

• Labour

• Etc.

• How can targeted automation deliver efficiency?

• Data-driven strategies to deliver significant cost reductions and open accessibility for patients worldwide